MedTrace Logo

Study for the Treatment of Ulcerative Colitis With Adacolumn

NCT00102193 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2008-09-08

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.

Conditions

Interventions

DEVICE

Adacolumn Apheresis System

Sponsors & Collaborators

  • Otsuka America Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Yosuke Komatsu, MD, PhD · Otsuka America Pharmaceutical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2006-07-31
Completion
2006-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102193 on ClinicalTrials.gov